Your browser doesn't support javascript.
loading
International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease.
van Rhee, Frits; Voorhees, Peter; Dispenzieri, Angela; Fosså, Alexander; Srkalovic, Gordan; Ide, Makoto; Munshi, Nikhil; Schey, Stephen; Streetly, Matthew; Pierson, Sheila K; Partridge, Helen L; Mukherjee, Sudipto; Shilling, Dustin; Stone, Katie; Greenway, Amy; Ruth, Jason; Lechowicz, Mary Jo; Chandrakasan, Shanmuganathan; Jayanthan, Raj; Jaffe, Elaine S; Leitch, Heather; Pemmaraju, Naveen; Chadburn, Amy; Lim, Megan S; Elenitoba-Johnson, Kojo S; Krymskaya, Vera; Goodman, Aaron; Hoffmann, Christian; Zinzani, Pier Luigi; Ferrero, Simone; Terriou, Louis; Sato, Yasuharu; Simpson, David; Wong, Raymond; Rossi, Jean-Francois; Nasta, Sunita; Yoshizaki, Kazuyuki; Kurzrock, Razelle; Uldrick, Thomas S; Casper, Corey; Oksenhendler, Eric; Fajgenbaum, David C.
Affiliation
  • van Rhee F; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR.
  • Voorhees P; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC.
  • Dispenzieri A; Division of Hematology/Oncology, Mayo Clinic, Rochester, MN.
  • Fosså A; Department of Oncology, Oslo University Hospital-Norwegian Radium Hospital, Oslo, Norway.
  • Srkalovic G; Herbert-Herman Cancer Center, Michigan State University College of Human Medicine, Lansing, MI.
  • Ide M; Department of Hematology, Takamatsu Red Cross Hospital, Takamatsu, Kagawa, Japan.
  • Munshi N; Dana-Farber Cancer Institute, VA Boston Healthcare System, Harvard Medical School, Boston, MA.
  • Schey S; Guys and St. Thomas' NHS Foundation Trust, London, United Kingdom.
  • Streetly M; Guys and St. Thomas' NHS Foundation Trust, London, United Kingdom.
  • Pierson SK; Division of Translational Medicine and Human Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Partridge HL; Division of Translational Medicine and Human Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Mukherjee S; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.
  • Shilling D; Division of Translational Medicine and Human Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Stone K; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR.
  • Greenway A; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR.
  • Ruth J; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Lechowicz MJ; Department of Hematology and Medical Oncology, and.
  • Chandrakasan S; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University, Atlanta, GA.
  • Jayanthan R; Department of Medicine, Baylor College of Medicine, Houston, TX.
  • Jaffe ES; National Cancer Institute, National Institutes of Health, Bethesda, MD.
  • Leitch H; Division of Hematology, Department of Medicine, St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada.
  • Pemmaraju N; Division of Cancer Medicine, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Chadburn A; Department of Pathology, Weill Cornell Medical College, New York, NY.
  • Lim MS; Department of Pathology and Laboratory Medicine, and.
  • Elenitoba-Johnson KS; Department of Pathology and Laboratory Medicine, and.
  • Krymskaya V; Penn Center for Pulmonary Biology, Pulmonary, Allergy, and Critical Care Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Goodman A; Division of Hematology/Oncology, Department of Medicine, University of California San Diego, La Jolla, CA.
  • Hoffmann C; University of Schleswig Holstein, Campus Kiel, Kiel, Germany.
  • Zinzani PL; ICH Study Center, Hamburg, Germany.
  • Ferrero S; Institute of Hematology "L. e A. Seràgnoli," University of Bologna, Bologna, Italy.
  • Terriou L; Division of Hematology, Department of Molecular Biotechnologies and Health Sciences University of Torino/AOU "Città della Salute e della Scienza di Torino," Turin, Italy.
  • Sato Y; Department of Internal Medicine-Hematology, Hôpital Claude Huriez-CHRU Lille, Lille, France.
  • Simpson D; Division of Pathophysiology, Okayama University Graduate School of Health Sciences, Okayama, Japan.
  • Wong R; North Shore Hospital, Auckland, New Zealand.
  • Rossi JF; Sir Y. K. Pao Centre for Cancer and Department of Medicine & Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong.
  • Nasta S; Department of Hematology, CHU de Montpellier, INSERM U1040, Université Montpellier I, Montpellier, France.
  • Yoshizaki K; Division of Hematology/Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Kurzrock R; Department of Organic Fine Chemicals, The Institute of Scientific and Industrial Research, Osaka University, Osaka, Japan.
  • Uldrick TS; Center for Personalized Therapy and Clinical Trials Office, UC San Diego Moore's Cancer Center, La Jolla, CA.
  • Casper C; Fred Hutch Global Oncology, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Oksenhendler E; Infectious Disease Research Institute, Departments of Medicine and Global Health, University of Washington, Seattle, WA; and.
  • Fajgenbaum DC; Department of Clinical Immunology, Hôpital Saint-Louis, Paris, France.
Blood ; 132(20): 2115-2124, 2018 11 15.
Article in En | MEDLINE | ID: mdl-30181172
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Castleman Disease / Adrenal Cortex Hormones / Antibodies, Monoclonal / Antineoplastic Agents Type of study: Clinical_trials / Guideline / Systematic_reviews Limits: Humans Language: En Journal: Blood Year: 2018 Type: Article Affiliation country: Argentina
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Castleman Disease / Adrenal Cortex Hormones / Antibodies, Monoclonal / Antineoplastic Agents Type of study: Clinical_trials / Guideline / Systematic_reviews Limits: Humans Language: En Journal: Blood Year: 2018 Type: Article Affiliation country: Argentina